Clinical Significance of NKD Inhibitor of WNT Signaling Pathway 1 (NKD1) in Glioblastoma

<div>Survival analyses of glioma patients based on the mRNA level of NKD1. The survival analyses were conducted using the Kaplan–Meier method according to the TCGA dataset, which reflected that higher-NKD1 mRNA level was correlated with better overall survival (a), cancer-specific survival (b), and progress-free survival (c) of glioma patients. Data were compared by log-rank test.</div>

Genetics Research

fig2

Figure 2

Figure 2: Clinical Significance of NKD Inhibitor of WNT Signaling Pathway 1 (NKD1) in Glioblastoma 